CMS NCD 54 Update: EC-IC Arterial Bypass Surgery Coverage Policy (2026)

CMS has issued a modification to National Coverage Determination (NCD) 54, which governs coverage of Extracranial-Intracranial (EC-IC) arterial bypass surgery under Medicare. This policy update, effective March 12, 2026, reaffirms and clarifies CMS's longstanding non-coverage position for EC-IC bypass when performed as a treatment for ischemic cerebrovascular disease. Billing teams and RCM directors at neurosurgery practices, vascular surgery groups, and inpatient hospital facilities need to understand exactly what this policy says—and what it means for claims.

Field Detail
Payer CMS (Centers for Medicare & Medicaid Services)
Policy Extracranial-Intracranial (EC-IC) Arterial Bypass Surgery
Policy Code NCD 54
Change Type Modified
Effective Date 2026-03-12
Impact Level High
Specialties Affected Neurosurgery, Vascular Surgery, Inpatient Hospital Facilities, Neurology
Key Action Audit any pending or recent EC-IC bypass claims billed to Medicare for ischemic cerebrovascular disease indications and halt submission until clinical necessity is verified against an approved indication.

What CMS NCD 54 Says About EC-IC Bypass Surgery Coverage

The Centers for Medicare & Medicaid Services explicitly excludes EC-IC arterial bypass surgery from Medicare coverage when the procedure is performed as a treatment for ischemic cerebrovascular disease of the carotid or middle cerebral arteries. This includes both the treatment and the prevention of strokes.

CMS's rationale is grounded in clinical evidence—or rather, the absence of it. The agency has determined that the premise underlying EC-IC bypass surgery (that bypassing narrowed arterial segments improves cerebral blood supply and reduces stroke risk) has not been demonstrated to be any more effective than no surgical intervention at all.

Because of this, CMS has concluded that EC-IC bypass surgery does not meet the "reasonable and necessary" standard under §1862(a)(1) of the Social Security Act when performed for ischemic cerebrovascular disease of the carotid or middle cerebral arteries. Claims submitted for this indication will be denied on medical necessity grounds.


Coverage vs. Non-Coverage: Where the Line Is Drawn

This policy is categorical in its non-coverage position for the specified indication. There is no tiered criteria, no prior authorization pathway, and no exception process described within NCD 54 for EC-IC bypass as a stroke treatment or prevention strategy.

It's worth being precise about the scope: the non-coverage applies specifically to ischemic cerebrovascular disease of the carotid or middle cerebral arteries. The NCD language does not speak to every possible clinical application of EC-IC bypass—but for the indications listed, denial is the expected outcome on any Medicare claim.

If your surgeons are performing EC-IC bypass for other indications (for example, certain cases of moyamoya disease, which is a distinct pathology not addressed in this NCD), those cases require separate coverage analysis and strong clinical documentation. NCD 54 as written does not govern those scenarios, but the absence of coverage guidance in a separate NCD does not automatically equal coverage. Consult your Medicare Administrative Contractor (MAC) for local coverage determination (LCD) guidance in those situations.


Medical Necessity Under CMS Policy: §1862(a)(1) and What It Means for Your Claims

When CMS invokes §1862(a)(1) of the Act, that's the statutory provision that excludes items and services not "reasonable and necessary" for the diagnosis or treatment of illness or injury. This is the most common basis for Medicare claim denials, and it carries significant weight.

For EC-IC bypass claims submitted for ischemic cerebrovascular disease, this means:

#Covered Indication
1No amount of supporting documentation will overcome the non-coverage determination. An ABN (Advance Beneficiary Notice of Noncoverage) should be issued to the patient prior to the procedure if there is any chance the service will be billed to Medicare.
2Claims will not be approved through the appeals process on medical necessity grounds alone, because the NCD itself establishes non-coverage—not the individual contractor.
3Provider liability applies if the patient was not informed. If a Medicare patient undergoes EC-IC bypass for stroke-related ischemic disease and was not given a proper ABN, your practice may be financially liable for the full claim amount.

Benefit Categories Affected by NCD 54

CMS identifies two benefit categories where this policy applies:

Both sides of the claim—the facility and the professional component—are subject to this non-coverage determination. Revenue cycle teams need to coordinate across both billing functions.


Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
Re-review every 24 monthsRe-review every 12 months with updated clinical documentation

Affected Codes

The policy data for NCD 54 does not list specific CPT, HCPCS, or ICD-10 codes. This is not unusual for older NCDs that predate current coding frameworks. The absence of explicit codes does not limit the policy's applicability—the non-coverage determination applies to the procedure and indication as described, regardless of which CPT code is used to report the service.

What this means for your coding team: If you are billing a surgical procedure that represents an EC-IC arterial bypass performed for ischemic cerebrovascular disease of the carotid or middle cerebral arteries, that claim is subject to NCD 54 denial—even without a code-specific mapping in the policy document.

Work with your coding staff and clinical documentation improvement (CDI) team to flag any operative reports that describe EC-IC bypass techniques when the primary diagnosis involves carotid artery disease, middle cerebral artery disease, or ischemic stroke prevention. Then apply appropriate claim-level edits or ABN workflows before submission.


This policy is now in effect (since 2026-03-12). Verify your claims match the updated criteria above.

What Your Billing Team Should Do

#Action Item
1

Conduct a 90-day lookback audit (by April 15, 2026). Pull all claims submitted to Medicare in the past 90 days that involve neurovascular bypass procedures. Cross-reference the operative reports against the NCD 54 non-coverage criteria to identify any claims billed for ischemic cerebrovascular disease of the carotid or middle cerebral arteries. If you find submitted claims that should have been denied or should have had an ABN on file, escalate immediately to your compliance officer.

2

Update your ABN workflow for EC-IC bypass cases now. Before the effective date of March 12, 2026, ensure that your front-end staff and surgical schedulers have a trigger in place to issue an ABN when EC-IC bypass is scheduled for a Medicare patient with a diagnosis of ischemic cerebrovascular disease, carotid artery stenosis, or middle cerebral artery disease. The ABN must be issued before the service is rendered—not after.

3

Coordinate with neurosurgery and vascular surgery on non-covered indications. Share this NCD update directly with your surgical staff. Surgeons need to understand that documenting "stroke prevention" or "ischemic cerebrovascular disease" as the indication for EC-IC bypass virtually guarantees a Medicare denial. For cases where an alternative indication exists, the operative note and clinical record must clearly and specifically support that indication—not the excluded one.

+ 2 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Get the Full Picture

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee